Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women

  • ES Tan*
  • , J van der Meer
  • , PJ de Kam
  • , PHJM Dunselman
  • , BJM Mulder
  • , CAPL Ascoop
  • , M Pfisterer
  • , KI Lie
  • , CABADAS Res Grp Intervuniv Cardiol
  • *Corresponding author for this work

    Research output: Contribution to journalArticleAcademicpeer-review

    54 Citations (Scopus)

    Abstract

    OBJECTIVES This retrospective study sought to assess differences in graft patency and clinical outcome between women and men after coronary artery bypass graft surgery (CABG).

    BACKGROUND A less favorable clinical outcome has been reported in women as compared with men. Its relation to graft patency has not been studied.

    METHODS We analyzed one-year follow-up data of 912 patients (120 women) who entered a randomized clinical drug trial. All patients received vein grafts; in 494 patients (56 women) internal mammary artery (IMA) grafts were also used. Graft patency was assessed by coronary angiography at one year. Primary clinical end points were myocardial infarction, revascularization procedures and death; secondary clinical end paints included recurrent angina, heart failure and arrhythmias.

    RESULTS Occlusion rates of vein grafts were 16.7% in women and 12.4% in men (odds ratio [OR] 1.62, 95% confidence interval [CI] 0.88 to 3.00, p = 0.12); occlusion rates of IMA grafts were 3.4% and 5.7% in women and men, respectively (OR 0.56 95% CI 0.08 to 3.96, p = 0.56). Primary clinical end points were observed in 16.7% of women and 9.2% of men (OR 1.97, 95% CI 1.10 to 3.34, p = 0.022), and any clinical end point in 41.7% of women and 25.8% of men (OR 2.06, 95%, CI 1.39 to 3.04, p = 0.0004). Myocardial infarction (15% ts. 7.6%, OR 2.15, 95% CI 1.24 to 3.75, p = 0.013) and recurrent angina (26.7% vs. 15.4%, OR 2.00, 95% CI 1.28 to 3.11, p = 0.004) occurred most frequently. Multivariate regression analysis did not identify gender as an independent risk factor for graft occlusion or the clinical end points. Graft occlusion was an independent predictor of the composite primary clinical end point (OR 2.75, 95% CI 1.59 to 4.75, p = 0.0003) and each of the secondary clinical end points. The observed differences were due to an imbalance of risk factors at baseline and to surgical and graft characteristics.

    CONCLUSIONS One-year occlusion rates of vein and IMA grafts were comparable in women and men. Clinical outcome was related to Raft patency and was less favorable in women owing to their uneven distribution of risk factors among both groups. (C) 1999 by the American College of Cardiology.

    Original languageEnglish
    Pages (from-to)1760-1768
    Number of pages9
    JournalJournal of the American College of Cardiology
    Volume34
    Issue number6
    Publication statusPublished - 15-Nov-1999

    Keywords

    • MYOCARDIAL-INFARCTION
    • SEX-DIFFERENCES
    • MAMMARY ARTERY
    • LONG-TERM
    • MORTALITY
    • SURVIVAL
    • DISEASE
    • CASS
    • OCCLUSION
    • EVENTS

    Fingerprint

    Dive into the research topics of 'Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women'. Together they form a unique fingerprint.

    Cite this